These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20724403)

  • 1. How long should treatments be continued?
    Craig JC; Webster AC; Loy C
    BMJ; 2010 Aug; 341():c4102. PubMed ID: 20724403
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 3. Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):371-2. PubMed ID: 16382376
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of survival curves in analysis of antipsychotic relapse studies.
    Davis JM; Dysken MW; Haberman SJ; Javaid JI; Chang SS; Killian GA
    Adv Biochem Psychopharmacol; 1980; 24():471-81. PubMed ID: 6105794
    [No Abstract]   [Full Text] [Related]  

  • 6. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 7. The CATIE study and its implications for antipsychotic drug use.
    Janicak PG
    Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Perazine in the treatment of psychotic disorders--research review].
    Kiejna A
    Psychiatr Pol; 2010; 44(3):427-34. PubMed ID: 20672521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial going on for 10 years - how is it possible?
    Mimica N; Folnegović-Smalc V; Uzun S; Kozumplik O
    Psychiatr Danub; 2009 Sep; 21(3):329. PubMed ID: 19794350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment guidelines for non-schizophrenic psychotic disorders?].
    Jäger M; Frasch K; Weinmann S; Becker T
    Psychiatr Prax; 2007 Nov; 34(8):370-6. PubMed ID: 17806003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of bromperidol in an open study].
    Hucker H
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():53-61. PubMed ID: 35480
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs for psychotic disorders.
    Treat Guidel Med Lett; 2010 Aug; 8(96):61-4; quiz two pages following last numbered page.. PubMed ID: 20651640
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of neuroleptics in psychotic states].
    Gayral LF; Escande M
    Rev Prat; 1984 Mar; 34(13):607-17. PubMed ID: 6143387
    [No Abstract]   [Full Text] [Related]  

  • 14. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of antipsychotic medication-time to rethink trial design.
    Speyer H; Begemann M; Albert N; Weller A; Nordentoft M; Veling W; Sommer IE; Allott K; Killackey E
    Lancet Psychiatry; 2020 Oct; 7(10):841-842. PubMed ID: 32949515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of use trials of long-acting tranquilizers in acute psychiatric syndromes].
    Ropert R; Lévy L; Ropert M
    Ann Med Psychol (Paris); 1973 Feb; 2(2):259-67. PubMed ID: 4147917
    [No Abstract]   [Full Text] [Related]  

  • 17. Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs.
    Angst J; Bech P; Bobon D; Engel R; Hippius H; Janzen GJ; Lecrubier Y; Lingjaerde O; Möller HJ; Montgomery S
    Pharmacopsychiatry; 1991 Sep; 24(5):149-52. PubMed ID: 1685571
    [No Abstract]   [Full Text] [Related]  

  • 18. [Brighter prospects for patients with psychoses? New neuroleptics may improve the long-term prognosis].
    Lindström L
    Lakartidningen; 1996 Nov; 93(45):3989-90. PubMed ID: 8984249
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis.
    Zhornitsky S; Rizkallah E; Pampoulova T; Chiasson JP; Stip E; Rompré PP; Potvin S
    J Clin Psychopharmacol; 2010 Aug; 30(4):417-24. PubMed ID: 20631559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.